investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
T Cell Survival
Alfred Singer
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
David M Hockenbery
Metabolism, Protein and miRNA Cross-Talk in Cell Cycle and Tumor Progression
All cancers but non-melanoma skin cancer
Charles Vinson
Gene Regulation and Function: The B-ZIP Proteins
All cancers but non-melanoma skin cancer
Dennis Klinman
Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides
All cancers but non-melanoma skin cancer
Barbara Felber
Prevention of AIDS
All cancers but non-melanoma skin cancer
Andrew B Lawson
Uncertainty in Spatial Health Analysis Due to Missingness and Aggregation Effects
All cancers but non-melanoma skin cancer
Steven E Artandi
Telomeres, Telomerase and Tumor Progression
All cancers but non-melanoma skin cancer
Swathi Arur
Erk-mediated regulation of Dicer and Drosha function in C. elegans
All cancers but non-melanoma skin cancer
Gregory A Lizee
Using the MHC class I cytoplasmic tail to control tumor Ag presentation by DCs
All cancers but non-melanoma skin cancer
Alexander Gimelbrant
(PQD4) Epigenetic loss of heterozygosity as a driver of the cancer field effect
All cancers but non-melanoma skin cancer